These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3112380)

  • 1. Two neutropenic patients with multiple resistant Pseudomonas aeruginosa septicaemia treated with ciprofloxacin.
    Bendig JW; Kyle PW; Giangrande PL; Samson DM; Azadian BS
    J R Soc Med; 1987 May; 80(5):316-7. PubMed ID: 3112380
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative efficacy of ciprofloxacin, azlocillin, imipenem/cilastatin and tobramycin in a model of experimental septicemia due to Pseudomonas aeruginosa in neutropenic mice.
    Ulrich E; Trautmann M; Krause B; Bauernfeind A; Hahn H
    Infection; 1989; 17(5):311-5. PubMed ID: 2599653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patients.
    Verhagen C; de Pauw BE; Donnelly JP; Williams KJ; de Witte T; Janssen TH
    J Infect; 1986 Sep; 13(2):125-31. PubMed ID: 3093589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Pseudomonas septicaemia following superficial colonization.
    Spiers AS
    Br Med J; 1974 Dec; 4(5947):770. PubMed ID: 4216391
    [No Abstract]   [Full Text] [Related]  

  • 5. Indications for systemic antibiotic prophylaxis in neutropenic patients.
    Spiers AS; Tattersall MH; Gaya H
    Br Med J; 1974 Nov; 4(5942):440-1. PubMed ID: 4214579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.
    Gordin FM; Hackbarth CJ; Scott KG; Sande MA
    Antimicrob Agents Chemother; 1985 Apr; 27(4):452-4. PubMed ID: 3159336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice.
    Fu KP; Hetzel N; Gregory FJ; Hung PP
    J Antimicrob Chemother; 1987 Oct; 20(4):541-6. PubMed ID: 3680089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of Pseudomonas aeruginosa septicaemia and meningitis with neutropenia--the presenting feature of hypogammaglobulinaemia.
    Johnston PG; Speller DC
    Postgrad Med J; 1977 Jun; 53(620):334-7. PubMed ID: 887532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and therapeutic features of pseudomonas aeruginosa septicaemia].
    Helm E; Stille W
    Dtsch Med Wochenschr; 1972 Oct; 97(42):1584-9. PubMed ID: 4116663
    [No Abstract]   [Full Text] [Related]  

  • 10. Scleral buckle infection with ciprofloxacin-resistant Pseudomonas aeruginosa.
    Chaudhry NA; Tabandeh H; Rosenfeld PJ; Miller D; Davis J
    Arch Ophthalmol; 1998 Sep; 116(9):1251. PubMed ID: 9747696
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.
    Scott RE; Robson HG
    Antimicrob Agents Chemother; 1976 Oct; 10(4):646-51. PubMed ID: 825035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of ciprofloxacin and colistin against Pseudomonas aeruginosa isolates from neutropenic patients: a possible approach to prophylaxis.
    Mannan P; Kibbler CC; Noone P
    J Antimicrob Chemother; 1988 Dec; 22(6):953-4. PubMed ID: 3149635
    [No Abstract]   [Full Text] [Related]  

  • 13. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa.
    Opal SM; Cross AS; Kelly NM; Sadoff JC; Bodmer MW; Palardy JE; Victor GH
    J Infect Dis; 1990 Jun; 161(6):1148-52. PubMed ID: 2140582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia.
    Kim J; Kang CI; Baek JY; Cho SY; Kim SH; Ko KS; Chung DR; Peck KR; Song JH
    Int J Antimicrob Agents; 2014 Apr; 43(4):391-3. PubMed ID: 24637223
    [No Abstract]   [Full Text] [Related]  

  • 16. Clostridium tertium septicemia in patients with neutropenia.
    Speirs G; Warren RE; Rampling A
    J Infect Dis; 1988 Dec; 158(6):1336-40. PubMed ID: 3198941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).
    Bergas A; Albasanz-Puig A; Fernández-Cruz A; Machado M; Novo A; van Duin D; Garcia-Vidal C; Hakki M; Ruiz-Camps I; Del Pozo JL; Oltolini C; DeVoe C; Drgona L; Gasch O; Mikulska M; Martín-Dávila P; Peghin M; Vázquez L; Laporte-Amargós J; Durà-Miralles X; Pallarès N; González-Barca E; Álvarez-Uría A; Puerta-Alcalde P; Aguilar-Company J; Carmona-Torre F; Clerici TD; Doernberg SB; Petrikova L; Capilla S; Magnasco L; Fortún J; Castaldo N; Carratalà J; Gudiol C
    Microbiol Spectr; 2022 Jun; 10(3):e0229221. PubMed ID: 35475683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empirical treatment of sepsis in neutropenic patients.
    Klastersky J
    Int J Antimicrob Agents; 2000 Oct; 16(2):131-3. PubMed ID: 11053794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.
    Guillot E; Sermet I; Ferroni A; Chhun S; Pons G; Zahar JR; Jullien V
    Pharmacotherapy; 2010 Dec; 30(12):1252-8. PubMed ID: 21114393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.